CN101519376B - 一种芳香环双酰胺螺环类药物模板的合成方法 - Google Patents
一种芳香环双酰胺螺环类药物模板的合成方法 Download PDFInfo
- Publication number
- CN101519376B CN101519376B CN200810043153A CN200810043153A CN101519376B CN 101519376 B CN101519376 B CN 101519376B CN 200810043153 A CN200810043153 A CN 200810043153A CN 200810043153 A CN200810043153 A CN 200810043153A CN 101519376 B CN101519376 B CN 101519376B
- Authority
- CN
- China
- Prior art keywords
- bisamide
- aromatic ring
- spiro
- reaction
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 19
- 229940079593 drug Drugs 0.000 title claims abstract description 18
- 238000010189 synthetic method Methods 0.000 title abstract 4
- 238000006243 chemical reaction Methods 0.000 claims abstract description 51
- 238000000034 method Methods 0.000 claims abstract description 29
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims abstract description 27
- 238000002360 preparation method Methods 0.000 claims abstract description 9
- KCKZIWSINLBROE-UHFFFAOYSA-N 3,4-dihydro-1h-naphthalen-2-one Chemical compound C1=CC=C2CC(=O)CCC2=C1 KCKZIWSINLBROE-UHFFFAOYSA-N 0.000 claims abstract description 7
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 3
- 238000003786 synthesis reaction Methods 0.000 claims abstract description 3
- 238000005576 amination reaction Methods 0.000 claims abstract 2
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 62
- 150000001875 compounds Chemical class 0.000 claims description 36
- -1 silicane nitrile Chemical class 0.000 claims description 28
- 239000002904 solvent Substances 0.000 claims description 23
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 12
- 150000002148 esters Chemical class 0.000 claims description 12
- YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 125000000217 alkyl group Chemical group 0.000 claims description 9
- KXZJHVJKXJLBKO-UHFFFAOYSA-N chembl1408157 Chemical compound N=1C2=CC=CC=C2C(C(=O)O)=CC=1C1=CC=C(O)C=C1 KXZJHVJKXJLBKO-UHFFFAOYSA-N 0.000 claims description 9
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 6
- 229960002073 sertraline Drugs 0.000 claims description 6
- VGKDLMBJGBXTGI-SJCJKPOMSA-N sertraline Chemical compound C1([C@@H]2CC[C@@H](C3=CC=CC=C32)NC)=CC=C(Cl)C(Cl)=C1 VGKDLMBJGBXTGI-SJCJKPOMSA-N 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 5
- 230000035484 reaction time Effects 0.000 claims description 5
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 4
- 235000015320 potassium carbonate Nutrition 0.000 claims description 4
- XONPDZSGENTBNJ-UHFFFAOYSA-N molecular hydrogen;sodium Chemical compound [Na].[H][H] XONPDZSGENTBNJ-UHFFFAOYSA-N 0.000 claims description 3
- 238000010792 warming Methods 0.000 claims description 3
- 239000003513 alkali Substances 0.000 claims description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 2
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 2
- 230000002045 lasting effect Effects 0.000 claims description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 2
- LVTJOONKWUXEFR-FZRMHRINSA-N protoneodioscin Natural products O(C[C@@H](CC[C@]1(O)[C@H](C)[C@@H]2[C@]3(C)[C@H]([C@H]4[C@@H]([C@]5(C)C(=CC4)C[C@@H](O[C@@H]4[C@H](O[C@H]6[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O6)[C@@H](O)[C@H](O[C@H]6[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O6)[C@H](CO)O4)CC5)CC3)C[C@@H]2O1)C)[C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1 LVTJOONKWUXEFR-FZRMHRINSA-N 0.000 claims 5
- 125000002924 primary amino group Chemical class [H]N([H])* 0.000 claims 2
- 238000005804 alkylation reaction Methods 0.000 abstract description 3
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 abstract 1
- 229940126062 Compound A Drugs 0.000 abstract 1
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 abstract 1
- 238000007333 cyanation reaction Methods 0.000 abstract 1
- UQUWSELRIJLNNT-UHFFFAOYSA-N inden-2-one Chemical compound C1=CC=CC2=CC(=O)C=C21 UQUWSELRIJLNNT-UHFFFAOYSA-N 0.000 abstract 1
- 239000012948 isocyanate Substances 0.000 abstract 1
- 150000002513 isocyanates Chemical class 0.000 abstract 1
- 238000005580 one pot reaction Methods 0.000 abstract 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 9
- WGQKYBSKWIADBV-UHFFFAOYSA-N aminomethyl benzene Natural products NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 8
- FTQWRYSLUYAIRQ-UHFFFAOYSA-N n-[(octadecanoylamino)methyl]octadecanamide Chemical compound CCCCCCCCCCCCCCCCCC(=O)NCNC(=O)CCCCCCCCCCCCCCCCC FTQWRYSLUYAIRQ-UHFFFAOYSA-N 0.000 description 8
- 238000010992 reflux Methods 0.000 description 8
- 238000005160 1H NMR spectroscopy Methods 0.000 description 7
- 125000003118 aryl group Chemical group 0.000 description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 238000001816 cooling Methods 0.000 description 6
- 230000006837 decompression Effects 0.000 description 6
- 238000001035 drying Methods 0.000 description 6
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 6
- 229910052938 sodium sulfate Inorganic materials 0.000 description 6
- 235000011152 sodium sulphate Nutrition 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 238000005406 washing Methods 0.000 description 6
- 229910052739 hydrogen Inorganic materials 0.000 description 5
- 239000001257 hydrogen Substances 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 3
- 238000010511 deprotection reaction Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- WGYKZJWCGVVSQN-UHFFFAOYSA-N mono-n-propyl amine Natural products CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 3
- 239000012074 organic phase Substances 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- CNPURSDMOWDNOQ-UHFFFAOYSA-N 4-methoxy-7h-pyrrolo[2,3-d]pyrimidin-2-amine Chemical compound COC1=NC(N)=NC2=C1C=CN2 CNPURSDMOWDNOQ-UHFFFAOYSA-N 0.000 description 2
- 108090000932 Calcitonin Gene-Related Peptide Proteins 0.000 description 2
- 102100025588 Calcitonin gene-related peptide 1 Human genes 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- XLJMAIOERFSOGZ-UHFFFAOYSA-N cyanic acid Chemical compound OC#N XLJMAIOERFSOGZ-UHFFFAOYSA-N 0.000 description 2
- 235000007715 potassium iodide Nutrition 0.000 description 2
- 229960004839 potassium iodide Drugs 0.000 description 2
- 150000003141 primary amines Chemical class 0.000 description 2
- 238000007363 ring formation reaction Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- NIDSRGCVYOEDFW-UHFFFAOYSA-N 1-bromo-4-chlorobutane Chemical compound ClCCCCBr NIDSRGCVYOEDFW-UHFFFAOYSA-N 0.000 description 1
- BLNVISNJTIRAHF-UHFFFAOYSA-N 4-chlorobenzamide Chemical compound NC(=O)C1=CC=C(Cl)C=C1 BLNVISNJTIRAHF-UHFFFAOYSA-N 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- RGDFODSQPRDTNE-UHFFFAOYSA-N CCNC(NCc1ccc[o]1)=O Chemical compound CCNC(NCc1ccc[o]1)=O RGDFODSQPRDTNE-UHFFFAOYSA-N 0.000 description 1
- SBHGBWFCLRIOIK-UHFFFAOYSA-N Cc1cc(CC(C2)(C(N3)=O)N(Cc4ccccc4)C3=O)c2cc1 Chemical compound Cc1cc(CC(C2)(C(N3)=O)N(Cc4ccccc4)C3=O)c2cc1 SBHGBWFCLRIOIK-UHFFFAOYSA-N 0.000 description 1
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- XCCGOLWOUVBUPN-UHFFFAOYSA-N N#CC1(Cc2cc([O]=C3Cc4ccccc4C3)ccc2C1)NCc1ccccc1 Chemical compound N#CC1(Cc2cc([O]=C3Cc4ccccc4C3)ccc2C1)NCc1ccccc1 XCCGOLWOUVBUPN-UHFFFAOYSA-N 0.000 description 1
- HFQODIAXKSWEHO-UHFFFAOYSA-N NCc1cc([O](c2cc(CC(C3)(C#N)NCc4ccc[o]4)c3cc2)=C2Cc3ccccc3C2)c[o]1 Chemical compound NCc1cc([O](c2cc(CC(C3)(C#N)NCc4ccc[o]4)c3cc2)=C2Cc3ccccc3C2)c[o]1 HFQODIAXKSWEHO-UHFFFAOYSA-N 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 230000029936 alkylation Effects 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- 230000007131 anti Alzheimer effect Effects 0.000 description 1
- 230000001430 anti-depressive effect Effects 0.000 description 1
- 230000000702 anti-platelet effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000000935 antidepressant agent Substances 0.000 description 1
- 229940005513 antidepressants Drugs 0.000 description 1
- OSYLPIYJUCCMTQ-UHFFFAOYSA-O azanium;cerium(3+);nitrate Chemical compound [NH4+].[Ce+3].[O-][N+]([O-])=O OSYLPIYJUCCMTQ-UHFFFAOYSA-O 0.000 description 1
- XKXHCNPAFAXVRZ-UHFFFAOYSA-N benzylazanium;chloride Chemical compound [Cl-].[NH3+]CC1=CC=CC=C1 XKXHCNPAFAXVRZ-UHFFFAOYSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 229940125782 compound 2 Drugs 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- SIIJRCRHAIMFNT-UHFFFAOYSA-N cyclopropanamine;hydrochloride Chemical compound Cl.NC1CC1 SIIJRCRHAIMFNT-UHFFFAOYSA-N 0.000 description 1
- FAMRKDQNMBBFBR-BQYQJAHWSA-N diethyl azodicarboxylate Substances CCOC(=O)\N=N\C(=O)OCC FAMRKDQNMBBFBR-BQYQJAHWSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- FAMRKDQNMBBFBR-UHFFFAOYSA-N ethyl n-ethoxycarbonyliminocarbamate Chemical compound CCOC(=O)N=NC(=O)OCC FAMRKDQNMBBFBR-UHFFFAOYSA-N 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 125000000623 heterocyclic group Chemical group 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- PYNUOAIJIQGACY-UHFFFAOYSA-N propylazanium;chloride Chemical compound Cl.CCCN PYNUOAIJIQGACY-UHFFFAOYSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 235000002639 sodium chloride Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 239000004577 thatch Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Indole Compounds (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200810043153A CN101519376B (zh) | 2008-02-27 | 2008-02-27 | 一种芳香环双酰胺螺环类药物模板的合成方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200810043153A CN101519376B (zh) | 2008-02-27 | 2008-02-27 | 一种芳香环双酰胺螺环类药物模板的合成方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101519376A CN101519376A (zh) | 2009-09-02 |
CN101519376B true CN101519376B (zh) | 2012-10-10 |
Family
ID=41080199
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200810043153A Active CN101519376B (zh) | 2008-02-27 | 2008-02-27 | 一种芳香环双酰胺螺环类药物模板的合成方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101519376B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8962860B2 (en) * | 2008-09-04 | 2015-02-24 | Probiodrug Ag | Inhibitors of glutaminyl cyclase |
EP3181550B1 (en) | 2010-07-20 | 2019-11-20 | Bayer Intellectual Property GmbH | Benzocycloalkenes as antifungal agents |
-
2008
- 2008-02-27 CN CN200810043153A patent/CN101519376B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN101519376A (zh) | 2009-09-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101062932A (zh) | 制备10,11-二氢-10-羟基-5H-二苯并[b,f]氮杂䓬-5-甲酰胺的对映选择性方法及其新晶形 | |
BR122021009062B1 (pt) | Processo para preparar um composto de fórmula i | |
WO2016202125A1 (zh) | Azd9291中间体及其制备方法 | |
JP2010053139A (ja) | 2−ヒドロキシ−n,n−ジメチル−3−[[2−(1(r)−5−メチル−2−フラニル)プロピル]アミノ]−3,4−ジオキソ−1−シクロブテン−1−イル]アミノ]ベンズアミドの合成 | |
CN1900075A (zh) | 一类四氢原小檗碱类化合物、其制备方法及其组合物和用途 | |
EP1572648B1 (en) | 3,6-disubstituted azabicyclo (3.1.0)-hexane derivatives as muscarinic receptor antagonists | |
JP2023552632A (ja) | アンドロゲン受容体及びホスホジエステラーゼ二重阻害剤としての新規化合物 | |
CN100402515C (zh) | 用作抗惊厥药的取代2-苯并[c]呋喃酮 | |
CN101519376B (zh) | 一种芳香环双酰胺螺环类药物模板的合成方法 | |
WO2022247676A1 (zh) | 一种二吡咯并吡啶结构的化合物、制备方法和医药用途 | |
JP2020504122A (ja) | ヘテロアリール化合物およびその使用 | |
CN107935997B (zh) | 一种奥斯替尼的合成方法 | |
IE51264B1 (en) | Taurine derivatives | |
IE903122A1 (en) | Benzazabicyclic carbamates as novel cholinesterase¹inhibitors | |
CN113444107B (zh) | 琥珀酰亚胺螺稠合磺内酰胺类化合物的合成方法及抗癌活性 | |
Chen et al. | Synthesis and Insecticidal Evaluation of Novel Phthalic Diamides Containing 1, 2, 3‐Triazoles via Click Reaction | |
US20120157482A1 (en) | Compounds and methods | |
RU2439072C1 (ru) | Способ получения 2,4,6,8-тетраазабицикло[3.3.0]октан-3,7-диона | |
Khodaee et al. | Efficient Synthesis of 5, 5-Disubstituted Bis-hydantoins/spirohydantoins and a Tetrakis-analogue: A Drug-like Multi-cyclic Scaffold | |
CN101555230A (zh) | 一种芳香环脲类螺环药物模板的合成方法 | |
CN107935866A (zh) | 盐酸达泊西汀杂质的制备方法 | |
KR100950629B1 (ko) | 8-알콕시-4-메틸-3,4-다이하이드로-퀴나졸린-2-일 아민 및5-ht5a 수용체 리간드로서의 이의 용도 | |
CN101863838A (zh) | 一种苯并双酰胺螺环类药物模板的合成方法 | |
Sugane et al. | Practical and efficient synthesis of the (R)-atropisomer of a 4-phenyl 1, 2, 4-triazole derivative as a selective GlyT1 inhibitor | |
Shen et al. | Catalyst-free one-pot synthesis of isoindolin-1-imine derivatives via three-component reaction |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20090902 Assignee: Suzhou AppTec Co., Ltd. Assignor: Shanghai Yaoming Kangde New Medicine Development Co., Ltd. Contract record no.: 2012990000838 Denomination of invention: Synthetic method for aromatic ring bisamide spiro drug template Granted publication date: 20121010 License type: Exclusive License Record date: 20121120 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
ASS | Succession or assignment of patent right |
Owner name: SUZHOU YAOMING KANGDE NEW DRUG DEVELOPMENT CO., LT Free format text: FORMER OWNER: SHANGHAI YAOMING KANGDE NEW MEDICINE DEVELOPMENT CO., LTD. Effective date: 20150526 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 200131 PUDONG NEW AREA, SHANGHAI TO: 215104 SUZHOU, JIANGSU PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20150526 Address after: Wuzhong Economic Development Zone in Suzhou City, Jiangsu province 215104 Jin Feng Road, No. 40 Patentee after: Suzhou medicine bright Kant's new drug development limited company Address before: 200131 Shanghai City, Pudong New Area Waigaoqiao Free Trade Zone Foote Road No. 288 Patentee before: Shanghai Yaoming Kangde New Medicine Development Co., Ltd. |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20161125 Address after: Wuzhong Economic Development Zone in Suzhou City, Jiangsu province 215104 Jin Feng Road, No. 40 Patentee after: Suzhou medicine bright Kant's new drug development limited company Patentee after: SHANGHAI YAOMING BIOTECHNOLOGY CO., LTD. Address before: Wuzhong Economic Development Zone in Suzhou City, Jiangsu province 215104 Jin Feng Road, No. 40 Patentee before: Suzhou medicine bright Kant's new drug development limited company |
|
TR01 | Transfer of patent right |
Effective date of registration: 20171212 Address after: Wuzhong Economic Development Zone in Suzhou City, Jiangsu province 215104 Jin Feng Road, No. 40 Patentee after: Suzhou medicine bright Kant's new drug development limited company Address before: Wuzhong Economic Development Zone in Suzhou City, Jiangsu province 215104 Jin Feng Road, No. 40 Co-patentee before: SHANGHAI YAOMING BIOTECHNOLOGY CO., LTD. Patentee before: Suzhou medicine bright Kant's new drug development limited company |
|
TR01 | Transfer of patent right | ||
CP01 | Change in the name or title of a patent holder |
Address after: 215104 No. 40 Fengjin Road, Wuzhong Economic Development Zone, Suzhou City, Jiangsu Province Patentee after: Suzhou AppTec Co., Ltd. Address before: 215104 No. 40 Fengjin Road, Wuzhong Economic Development Zone, Suzhou City, Jiangsu Province Patentee before: Suzhou medicine bright Kant's new drug development limited company |
|
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: 215104 No. 40 Fengjin Road, Wuzhong Economic Development Zone, Suzhou City, Jiangsu Province Patentee after: Suzhou AppTec Co., Ltd. Address before: 215104 No. 40 Fengjin Road, Wuzhong Economic Development Zone, Suzhou City, Jiangsu Province Patentee before: Suzhou medicine bright Kant's new drug development limited company |
|
CP01 | Change in the name or title of a patent holder | ||
CP02 | Change in the address of a patent holder | ||
CP02 | Change in the address of a patent holder |
Address after: 215104 No. 1318 Wuzhong Avenue, Wuzhong District, Suzhou City, Jiangsu Province Patentee after: Suzhou AppTec Co., Ltd. Address before: 215104 No. 40 Fengjin Road, Wuzhong Economic Development Zone, Suzhou City, Jiangsu Province Patentee before: Suzhou AppTec Co., Ltd. |